Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
Latest:
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates
From FDA to MHRA: are drug regulators for hire?
U.S. has now allocated over $80 billion to Kiev.
Sure, financial markets and national currencies are imploding worldwide, but the military industrial regime needs to keep churning, and that means pumping more money into the Slava Slush Fund.
Slava Slush Fund: despite economic crisis, Congress readies $12 billion more for Ukraine
Related:
There’s no debating it: Biden will get billions in new Ukraine aid
“Oversight of Ukraine aid is sorely needed,” Julia Gledhill, a defense analyst for the Project on Government Oversight (POGO), tells Responsible Statecraft. “The State and Defense departments are handling billions of dollars in Ukraine funding, but neither have permanent inspectors general in place to investigate and prevent abuse of funds.”
Senate advances spending bill for Ukraine with $12 Billion
After the Senate invoked cloture for the legislative vehicle to carry out the CR, it will now be up for a full vote by the Senate. The House will next vote on it, likely on Friday.
Report: US Preparing $1.1 Billion Arms Package for Ukraine
The weapons package will likely include HIMARS rocket systems, HIMARS ammunition, counter-drone systems, radar systems, training, and technical support.
The arms package is expected to be provided to Kyiv using the Ukraine Security Assistance Initiative (USAI) as opposed to sending the arms directly from US military stockpiles. The USAI allows the Biden administration to purchase military equipment for Ukraine from the US arms industry.
Crist said that industry officials are “surprised and disappointed” by the situation, especially because the USTR report about potentially unfair Chinese trade practices didn’t even mention medical technology.
According to Crist, that $5 billion number could be higher if you take into account component parts like circuit boards that are not necessarily listed under medical devices on the Harmonized Trade Schedule.
— Read on www.medicaldesignandoutsourcing.com/trump-tariffs-take-5b-bite-medical-device-industry/
“Think of products like gauze that are made in Band-Aids,” Einhorn said. “Think of other products like medical gloves.”
He continued: “These products are used on an everyday basis not only on the professional side such as physician offices, surgery centers, and hospitals, but also on the consumer side — products you’ll buy in a pharmacy. And those products will be somewhat affected somewhere between 10% and 25%.”
— Read on finance.yahoo.com/news/trade-war-consumers-medical-supplies-144533487.html
Ms. Cat’s Chronicles 